Caspase molecule is a very conserved class of protease-like molecules. Caspases are a family of cysteine proteases that play a crucial role in apoptosis (programmed cell death), necrosis and inflammation. The enzyme has several isoforms of structure, the most common of which are Caspase-2, Caspase-3. Clinical studies have shown that increased levels of cellular apoptosis and cysteinase activity are frequently observed at sites of cellular injury in acute (myocardial infarction, stroke, sepsis) and chronic states (neurodegenerative diseases, especially Alzheimer's, Parkinson's and Huntington's disease). Therefore, inhibition of caspase activity aims to reduce cell death, and the development of small molecule compounds that modulate CASP activity has significant therapeutic potential.
BOC Sciences can design a novel caspase targeted library to deliver various drug-like compounds with predicted inhibiting activity against caspase. Our well-designed caspase screening library can be used for cell survival, proliferation and apoptosis studies in drug discovery programs dedicated to many pressing diseases and disorders.
Figure 1. Canonical caspase substrate-binding pocket. (Duclos, C.; et al. 2017)
At BOC Sciences, two receptor-based approaches: pharmacophore screening and molecular docking are combined to build this library.
Figure 2. Schematic representation of major intracellular trafficking pathways. (Duclos, C.; et al. 2017)
BOC Sciences provides professional, rapid and high-quality services of Caspase Targeted Library design at competitive prices for global customers. Personalized and customized services of Caspase Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.